/Companies

Opus KSD

Halifax, US · Delaware corporation

Find your way into Opus KSD

Sign up to see every warm intro you have to Opus KSD

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Opus KSD team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Opus KSD designs, manufactures, and distributes the SubQ-It! dermal fastener, a device for closing surgical incisions subcutaneously at the speed of a stapler but without staples. It is aimed at surgeons and operating room staff as an alternative to metal staples and sutures.

Founders & leadership

CH
Charles H RogersExecutive
SA
Saud AlturkiNamed on SEC filing
CM
Christos MonovoukasNamed on SEC filing
WS
Wei ShenNamed on SEC filing

Board

PA
Porter AndersonBoard director
KD
Kenneth DanielsonBoard director

Reported raises · per SEC filings

Form D private placements

$1.5M disclosed across 3 rounds · 2016–2026

▶$680.8KraisedOct 2026 · 16 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Charles RogersDirector
  • Saud AlturkiDirector
  • Porter AndersonDirector
  • Kenneth DanielsonDirector
  • Christos MonovoukasDirector
  • Wei ShenDirector
Offering amount
$680.8K
Amount sold
$680.8K
Minimum investment
$10K
First sale
Sep 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$300KraisedOct 2023 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Porter AndersonDirector
  • Saud Abdulaziz al-TurkiDirector
  • Wei ShenDirector
  • Charles H RogersExecutive Officer, Director
  • Kenneth S DanielsonDirector
Offering amount
$1M
Amount sold
$300K
Minimum investment
$50K
First sale
Oct 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$500KraisedMar 2016 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Charles H RogersExecutive Officer, Director
  • Porter AndersonDirector
  • Kenneth DanielsonDirector
Offering amount
$1M
Amount sold
$500K
Minimum investment
$1K
First sale
Feb 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 2

Companies working in the same space as Opus KSD.

Non-dilutive funding · 2 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase II2015$752.1K
National Institutes of Health (NIH)National Institutes of HealthPhase I2012$147.2K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does Opus KSD do?
Opus KSD designs, manufactures, and distributes the SubQ-It! dermal fastener, a device for closing surgical incisions subcutaneously at the speed of a stapler but without staples. It is aimed at surgeons and operating room staff as an alternative to metal staples and sutures.
How much funding has Opus KSD raised?
Opus KSD has disclosed $1.5M raised across 3 rounds.
Where is Opus KSD headquartered?
Opus KSD is headquartered in Halifax, US.